{"id":"https://openalex.org/W4361884065","doi":"https://doi.org/10.1158/1078-0432.22455218","title":"Supplementary Table 1 from Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303","display_name":"Supplementary Table 1 from Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361884065","doi":"https://doi.org/10.1158/1078-0432.22455218"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22455218","doi":"https://doi.org/10.1158/1078-0432.22455218","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22455218","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22455218","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063134810","display_name":"Amanda K. Psyrri","orcid":"https://orcid.org/0000-0002-4321-766X","observed_orcids":["https://orcid.org/0000-0002-4321-766X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Psyrri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044564476","display_name":"Ju\u2010Whei Lee","orcid":"https://orcid.org/0000-0003-2068-8511","observed_orcids":["https://orcid.org/0000-0003-2068-8511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ju-Whei Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005822897","display_name":"Eirini Pectasides","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eirini Pectasides","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026898666","display_name":"Maria Vassilakopoulou","orcid":"https://orcid.org/0000-0002-3129-2259","observed_orcids":["https://orcid.org/0000-0002-3129-2259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Vassilakopoulou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015216961","display_name":"Efstratios K. Kosmidis","orcid":"https://orcid.org/0000-0001-9496-4828","observed_orcids":["https://orcid.org/0000-0001-9496-4828"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Efstratios K. Kosmidis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023000705","display_name":"Barbara Ann Burtness","orcid":"https://orcid.org/0000-0003-4660-1859","observed_orcids":["https://orcid.org/0000-0003-4660-1859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara A. Burtness","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027326018","display_name":"David L. Rimm","orcid":"https://orcid.org/0000-0001-5820-4397","observed_orcids":["https://orcid.org/0000-0001-5820-4397"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David L. Rimm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109561731","display_name":"Harold J. Wanebo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harold J. Wanebo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034392417","display_name":"Arlene A. Forastiere","orcid":"https://orcid.org/0000-0003-2238-3682","observed_orcids":["https://orcid.org/0000-0003-2238-3682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arlene A. Forastiere","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11669","display_name":"Head and Neck Surgical Oncology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.953000009059906},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.6899999976158142},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.9810000061988831},{"id":"https://openalex.org/keywords/resectable-cancer","display_name":"resectable tumors","score":0.6809999942779541},{"id":"https://openalex.org/keywords/primary-antibodies","display_name":"primary antibodies","score":0.7599999904632568},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.9829999804496765}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9425703287124634},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6839507222175598},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.649939775466919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6486152410507202},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.6435356140136719},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18760111927986145},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.11701226234436035}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22455218","doi":"https://doi.org/10.1158/1078-0432.22455218","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22455218","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22455218.v1","doi":"https://doi.org/10.1158/1078-0432.22455218.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22455218.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Prognostic_Biomarkers_in_Phase_II_Trial_of_Cetuximab-Containing_Induction_and_Chemoradiation_in_Resectable_HNSCC_Eastern_Cooperative_Oncology_Group_E2303/22455218/1/files/39906344.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22455218","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Prognostic_Biomarkers_in_Phase_II_Trial_of_Cetuximab-Containing_Induction_and_Chemoradiation_in_Resectable_HNSCC_Eastern_Cooperative_Oncology_Group_E2303/22455218","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22455218","doi":"https://doi.org/10.1158/1078-0432.22455218","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22455218","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361884065.pdf","grobid_xml":"https://content.openalex.org/works/W4361884065.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2127265232","https://openalex.org/W4361958824","https://openalex.org/W2603935706","https://openalex.org/W2594966530","https://openalex.org/W2129707741","https://openalex.org/W2972614630","https://openalex.org/W2248909429","https://openalex.org/W6892577282","https://openalex.org/W2887433064","https://openalex.org/W7162679479"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"81K,":[3],"Primary":[4],"antibodies":[5],"Used":[6],"for":[7],"Immunohistochemistry.":[8]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}